Literature DB >> 11916191

Are anxiety and depression related to gastrointestinal symptoms in the general population?

T Tangen Haug1, A Mykletun, A A Dahl.   

Abstract

BACKGROUND: In clinical studies there is a strong relationship between gastrointestinal symptoms, anxiety and depression. The results may be biased, however, since anxiety and depression will influence the decision to consult a doctor. The aim of this study was to investigate the relationship between these symptoms in the population.
METHODS: In the Health Study of Nord-Trøndelag County of Norway (HUNT) a questionnaire concerning physical and mental health, demographic and life-style factors was sent to all inhabitants aged 20 years and above (a total of 94,197 persons). Valid questionnaires were returned by 62,651 persons (66.5%). Presence of nausea, heartburn, diarrhoea and constipation during the last year was self-reported. Anxiety disorders and depression were based on self-ratings of the Hospital Anxiety and Depression Scale (HADS).
RESULTS: 48% of the population reported one or more of the four gastrointestinal symptoms. Based on the HADS ratings, 15.3% of the population had an anxiety disorder and 10.4% a depression. Anxiety disorder was most strongly associated with nausea (OR 3.42). Anxiety was also associated with heartburn, diarrhoea and constipation, but weaker than with nausea. Depression was less strongly associated with the four gastrointestinal symptoms. Demographic factors, life-style factors and extra-gastrointestinal complaints could not explain the effect of anxiety disorders and depression on these gastrointestinal symptoms.
CONCLUSIONS: In this population study there was a strong relationship between gastrointestinal symptoms, anxiety disorders and depression. These findings suggest that mental disorders in patients with gastrointestinal symptoms are not merely a consequence of selection bias in patient materials but connected to the symptoms themselves.

Entities:  

Mesh:

Year:  2002        PMID: 11916191     DOI: 10.1080/003655202317284192

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  56 in total

1.  Gastrointestinal inflammation and associated immune activation in schizophrenia.

Authors:  Emily G Severance; Armin Alaedini; Shuojia Yang; Meredith Halling; Kristin L Gressitt; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; F Markus Leweke; Faith B Dickerson; Robert H Yolken
Journal:  Schizophr Res       Date:  2012-03-24       Impact factor: 4.939

Review 2.  American Gastroenterological Association technical review on constipation.

Authors:  Adil E Bharucha; John H Pemberton; G Richard Locke
Journal:  Gastroenterology       Date:  2013-01       Impact factor: 22.682

3.  Evidence-based clinical practice guidelines for functional dyspepsia.

Authors:  Hiroto Miwa; Motoyasu Kusano; Tomiyasu Arisawa; Tadayuki Oshima; Mototsugu Kato; Takashi Joh; Hidekazu Suzuki; Kazunari Tominaga; Koji Nakada; Akihito Nagahara; Seiji Futagami; Noriaki Manabe; Akio Inui; Ken Haruma; Kazuhide Higuchi; Koji Yakabi; Michio Hongo; Naomi Uemura; Yoshikazu Kinoshita; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2015-01-14       Impact factor: 7.527

4.  Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life.

Authors:  Xiao-Jun Yang; Hong-Mei Jiang; Xiao-Hua Hou; Jun Song
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

5.  A Structural Equation Model of HIV-related Symptoms, Depressive Symptoms, and Medication Adherence.

Authors:  Moka Yoo-Jeong; Drenna Waldrop-Valverde; Katryna McCoy; Raymond L Ownby
Journal:  J HIV AIDS       Date:  2016-04-06

6.  Prevalence of Psychiatric Comorbidity in Symptomatic Gastroesophageal Reflux Subgroups.

Authors:  Mustafa Melih Bilgi; Rukiye Vardar; Esra Yıldırım; Baybars Veznedaroğlu; Serhat Bor
Journal:  Dig Dis Sci       Date:  2016-08-26       Impact factor: 3.199

7.  Effects of fluoxetine on mast cell morphology and protease-1 expression in gastric antrum in a rat model of depression.

Authors:  Zhen-Hua Chen; Ling Xiao; Ji-Hong Chen; He-Shen Luo; Gao-Hua Wang; Yong-Lan Huang; Xiao-Ping Wang
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

8.  Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women.

Authors:  Arnstein Mykletun; Felice Jacka; Lana Williams; Julie Pasco; Margaret Henry; Geoffrey C Nicholson; Mark A Kotowicz; Michael Berk
Journal:  BMC Gastroenterol       Date:  2010-08-05       Impact factor: 3.067

9.  L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats.

Authors:  Miro Smriga; Kunio Torii
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

10.  Effect of fluoxetine on depression-induced changes in the expression of vasoactive intestinal polypeptide and corticotrophin releasing factor in rat duodenum.

Authors:  Yong-Lan Huang; Jie-Ping Yu; Gao-Hua Wang; Zhen-Hua Chen; Qing Wang; Ling Xiao
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.